MEDICAL COSTS ASSOCIATED WITH RHEUMATOID ARTHRITIS IN TURKEY: AN ANALYSIS OF REAL-WORLD DATA

被引：0
|
作者：
Baser, O. [1 ,2 ]
Burkan, A. [3 ]
Baser, E. [1 ]
Koselerli, R. [3 ]
Ertugay, E. [3 ]
Altinbas, A. [4 ]
机构：
[1] STATinMED Res, Istanbul, Turkey
[2] Univ Michigan, Div Rheumatol, Ann Arbor, MI 48109 USA
[3] Social Secur Inst, Ankara, Turkey
[4] Diskapi Yildirim Beyazit Educ & Res Hosp, Gastroenterol Clin, Ankara, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1029 / 1030
页数：2
相关论文
共 50 条
  • [31] Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine Learning
    Johansson, Fredrik D.
    Collins, Jamie E.
    Yau, Vincent
    Guan, Hongshu
    Kim, Seoyoung C.
    Losina, Elena
    Sontag, David
    Stratton, Jacklyn
    Trinh, Huong
    Greenberg, Jeffrey
    Solomon, Daniel H.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (09) : 1364 - 1370
  • [32] USE OF REAL-WORLD DATA IN COST-EFFECTIVENESS ANALYSIS OF SEQUENTIAL BIOLOGIC TREATMENT FOR RHEUMATOID ARTHRITIS
    Singh, J.
    Stevenson, M. D.
    Hyrich, K.
    Gillies, C.
    Abrams, K.
    Bujkiewicz, S.
    VALUE IN HEALTH, 2022, 25 (12) : S373 - S374
  • [33] Prevalence and Risk Factors of Cardiovascular Disease in Rheumatoid Arthritis Patients: A Comparative Analysis of Real-World Data
    Tekeoglu, Senem
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 5859 - 5868
  • [34] Use Of Real-World Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis
    Singh, Janharpreet
    Stevenson, Matt
    Hyrich, Kimme
    Gillies, Clare
    Abrams, Keith
    Bujkiewicz, Sylwia
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP49 - NP50
  • [35] EFFECTIVENESS OF A SWITCH FROM TOFACITINIB TO BARICITINIB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA IN SWITZERLAND
    Kellerhals, S.
    Amsler, J.
    Schulze-Koops, H.
    Hugle, T.
    Nissen, M. J.
    Paul, H.
    Kyburz, D.
    Muller, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1161 - 1161
  • [36] REAL-WORLD EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Diederik, D. C.
    Durez, P.
    Lenaerts, J.
    Westhovens, R.
    Verschueren, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1398 - 1399
  • [37] THE REAL-WORLD SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hyrich, Kimme
    RHEUMATOLOGY, 2017, 56 : 24 - 25
  • [38] Real-world experience with filgotinib for rheumatoid arthritis in Germany
    Schultz, Olaf
    Fiehn, Christoph
    Kneitz, Christian
    Picker, Nils
    Kromer, Daniel
    Zignani, Monia
    De Leonardis, Francesco
    Orzechowski, Hans-Dieter
    Gurrath, Margot
    Krueger, Klaus
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2025, 84 (01): : 39 - 47
  • [39] Real-world experience with tofacitinib for the treatment of rheumatoid arthritis
    Caporali, Roberto
    Zavaglia, Daniela
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 485 - 495
  • [40] Antifibrotics in rheumatoid arthritis-associated interstitial lung disease - real-world data from a nationwide cohort
    Duarte, A. C.
    Gomes, C. Marques
    Correia, M.
    Mendes, B.
    Mazeda, C.
    Guimaraes, F.
    Abelha-Aleixo, J.
    Guerra, M.
    da Costa, R. Pereira
    Meirinhos, T.
    Santos, Mj
    ARP RHEUMATOLOGY, 2024, 3 (03):
12345